Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Abingdon Health Plc LSE:ABDX London Ordinary Share GB00BLF79J41 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.50 -1.64% 90.00 85.00 95.00 91.50 88.50 91.50 104,304 15:22:59
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0

Abingdon Health PLC Notice of Interim Results

23/02/2021 7:00am

UK Regulatory (RNS & others)


Abingdon Health (LSE:ABDX)
Historical Stock Chart


From Jan 2021 to Feb 2021

Click Here for more Abingdon Health Charts.

TIDMABDX

RNS Number : 9619P

Abingdon Health PLC

23 February 2021

Notice of Interim Results

York, U.K. 23 February 2021: Abingdon Health ("Abingdon" or "the Company"), a leading international developer and manufacturer of high quality and effective rapid tests, will announce its maiden Interim Results for the six months ended 31 December 2020 on Tuesday 9 March 2021.

Chris Yates, Chief Executive Officer, and Melanie Ross, Chief Financial Officer, will host a virtual briefing for sell-side analysts at 11:00 AM on the day of the results.

For more details or to attend the virtual briefing, please contact abingdonhealth@consilium-comms.com.

- Ends-

Enquiries:

 
 Abingdon Health 
  plc 
 Chris Yates                    Chief Executive Officer     Via Consilium 
 Melanie Ross                   Chief Financial Officer 
 Chris Hand                     Non-Executive Chairman 
 
 N+1 Singer                     Sole Broker and Nominated Adviser 
                                                            Tel: +44 (0) 20 7496 
 Shaun Dobson, Peter Steel,                                  3000 
 Alex Bond (Corporate Finance) 
 Tom Salvesen (Corporate Broking) 
 
                                                            Tel: +44 (0) 203 709 
 Consilium                      Financial PR                 5700 
 Matthew Neal                                 abingdonhealth@consilium-comms.com 
 Mary-Jane Elliott 
 Lindsey Neville 
 
 

About Abingdon Health

Abingdon Health is a world leading developer and manufacturer of high-quality rapid tests across all industry sectors, including healthcare and COVID-19. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and has also developed and marketed its own labelled tests.

The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx(R) , a customisable image capturing technology that transforms a smartphone into a self-sufficient, standalone lateral-flow reader.

Founded in 2008, Abingdon Health is headquartered in York, England.

https://www.abingdonhealth.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORFFFVIFLIFFIL

(END) Dow Jones Newswires

February 23, 2021 02:00 ET (07:00 GMT)

1 Year Abingdon Health Chart

1 Year Abingdon Health Chart

1 Month Abingdon Health Chart

1 Month Abingdon Health Chart
ADVFN Advertorial
Your Recent History
LSE
ABDX
Abingdon H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210227 13:59:22